Skip to main content

Table 1 Patient characteristics

From: The effect of selective internal radiation therapy with yttrium-90 resin microspheres on lung carbon monoxide diffusion capacity

All patients (n = 40)
 Age, year 56.9 ± 10.8
 Male gender, n (%) 28 (70.0%)
 Tumor type, n (%)
  Colon 20 (50.0%)
  Hepatocellular carcinoma 7 (17.5%)
  Pancreas Ca 6 (15.0%)
  Others* 7 (17.5%)
 Lung shunt fraction, % (1st treatment) 6.7 ± 2.6
  Lung shunt fraction with 5–10%, n (%) 26 (65%)
  Lung shunt fraction with 10–15%, n (%) 6 (15%)
  Lung shunt fraction with 15–20%, n (%) 0 (0%)
 Treatment radiation dose, GBq (1st treatment) 1.6 ± 0.3
 Lung exposure dose, Gy (1st treatment) 6.7 ± 2.8
Patients receiving two treatments (n = 11)
 Age, year 58.5 ± 11.0
 Male gender, n (%) 7 (63.6%)
 Tumor type, n (%)  
  Colon 6 (54.5%)
  Hepatocellular carcinoma 2 (18.2%)
  Pancreas Ca 1 (9.1%)
  Others† 2 (18.2%)
 Lung shunt fraction, % (2nd treatment) 7.5 ± 3.0
  Lung shunt fraction with 5–10%, n (%) 6 (55%)
  Lung shunt fraction with 10–15%, n (%) 1 (9%)
  Lung shunt fraction with 15–20%, n (%) 2 (18%)
 Treatment radiation dose, GBq (2nd treatment) 1.6 ± 0.2
 Lung exposure dose, Gy (2nd treatment) 7.7 ± 3.0
  1. Unless otherwise stated, data are presented as mean ± SD
  2. *Gastric ca (n = 2), parotid ca (2), breast ca (1), cholangiocarcinoma (1), unknown (1)
  3. †Cholangiocarcinoma (1), unknown (1)